Dr. Daniel Sze, MD

• Interventional Radiology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Stanford University

  Fellowship Hospital, 1997

• University Calif San Francisco

  Residency Hospital, 1996

• Calif Pacific Mc

  Internship Hospital, 1992

• Stanford University School Of Medicine

  Medical School, 1991

• Stanford University, Biophysics

  1990

• Harvard Medical School

  Undergraduate School, 1983

• A global evaluation of advanced dosimetry in transarterial radioembolization of hepatocellular carcinoma with Yttrium-90: the TARGET study, 2022-04-08

• Long-term outcomes following 90Y Radioembolization of neuroendocrine liver metastases: evaluation of the radiation-emitting SIR-spheres in non-resectable liver tumor (RESiN) registry, 2022-03-01

• Overall survival and toxicity of Y90 radioembolization for hepatocellular carcinoma patients in Barcelona Clinic Liver Cancer stage C (BCLC-C), 2022-11-17

• A Phase I, multicenter, open-label trial to evaluate the safety of talimogene laherparepvec (T-VEC) injected into liver tumors, 2015-11-04

• Spontaneous Regression of Hepatocellular Carcinoma: When the Immune System Stands Up to Cancer, 2021-03-16

• Fusion dual-tracer SPECT-based hepatic dosimetry predicts outcome after radioembolization for a wide range of tumour cell types, 2015-04-28

• Recommendations for radioembolisation after liver surgery using yttrium-90 resin microspheres based on a survey of an international expert panel, 2017-07-03

• International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheres, 2021-01-12

• Efficacy and Safety of Trans-Arterial Yttrium-90 Radioembolization in Patients with Unresectable Liver-Dominant Metastatic or Primary Hepatic Soft Tissue Sarcomas, 2022-01-10

• Clinical, dosimetric, and reporting considerations for Y-90 glass microspheres in hepatocellular carcinoma: updated 2022 recommendations from an international multidisciplinary working group, 2022-09-17